Clinical Trial Detail

NCT ID NCT02012296
Title Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Chicago
Indications

prostate cancer

Therapies

Mifepristone

Enzalutamide

Age Groups: adult

No variant requirements are available.